News & Events CTI Announces Expansion into Israel

CTI Announces Expansion into Israel

April 9, 2018

CTI Announces Expansion Into Israel

FOR IMMEDIATE RELEASE [Covington, KY ~ April 9, 2018] CTI Clinical Trial and Consulting Services (CTI), a multi-national, privately held, full-service contract research organization announces it has expanded its presence into Israel with the completion of its incorporation in Israel under the wholly-owned subsidiary, CTI Clinical Trial & Consulting Services Israel.

CTI specializes in clinical research programs involving chronically and critically ill patient populations and has been steadily increasing its global coverage over the past decade. The expansion into Israel is part of the company's continued efforts to increase capacity for clinical research across the world.

“We have had ongoing relationships with research leaders in the area for several years,” explains Patrick Earley, Vice President, International. “The expansion will allow us to continue to further enhance those collaborations as well as our ability to find the complex and rare patient populations in which we specialize."

CTI has opened more than a dozen offices over the past few years and currently have more than 25 offices worldwide to serve nearly 120 pharmaceutical, biotechnology, and medical device clients in the drug development industry across North America, Europe, South America, Pac-Asia, and Africa.

About CTI Clinical Trial and Consulting Services

CTI Clinical Trial and Consulting Services is a global, privately held, full-service contract research organization (CRO), delivering a complete spectrum of clinical trial and consulting services throughout the lifecycle of development, from concept to commercialization. CTI’s focused therapeutic approach provides pharmaceutical, biotechnology, and medical device firms with clinical and disease area expertise in rare diseases, regenerative medicine/gene therapy, immunology, transplantation, nephrology, hematology/oncology, neurology, infectious diseases, hepatology, cardiopulmonary, and pediatric populations. CTI also offers a fully integrated multi-specialty clinical research site that conducts phase I-IV trials. CTI has a passion for helping life-changing therapies succeed in chronically and critically ill patient populations. With clinical trial experience across 6 continents, CTI partners with research sites, patients, and sponsors to fulfill unmet medical needs. CTI is headquartered in the Greater Cincinnati, OH area, with operations across North America, Europe, Latin America, and Asia-Pacific. For more information visit www.ctifacts.com

Subscribe to our mailing list

* indicates required